Company profilePharmaceutical#274 of 1,318 in Pakistan✓ No DRAP alerts

Lucky Core Industries Limited DML: 000363

Pharmaceutical company · 67 brands · 122 molecules

Ranked #30 of 79 companies in Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives

67 registered products 22 pharmaceutical brands 122 distinct molecules 0 DRAP alerts

Company overview

67
registered products
22
pharmaceutical brands
122
distinct molecules
12
therapeutic classes
0
DRAP alerts

Lucky Core Industries Limited DML: 000363 is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 67 product registrations across 122 distinct molecules. Its portfolio is concentrated in Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives and Other Beta-Lactam, Cephalosporins & Penems. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Lucky

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20261

Top molecules by brand count

Calcium3 brands
Paracetamol2 brands
Lumefantrine2 brands
Artemether2 brands
Ethambutol2 brands
Rivaroxaban2 brands
Acetaminophen ...... 10 Mg1 brand

Therapeutic classes

Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 4Other Beta-Lactam, Cephalosporins & Penems · 3Quinolone Antibacterials · 2Corticosteroids, Systemic Use · 2Macrolides, Lincosamides And Streptogramins · 1Antivirals For Systemic Use · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1Beta-Lactamase Sensitive Penicillins · 1Muscle Relaxant · 1Vaccine · 1Anti-Infectives · 1Other Analgesics And Antipyretics · 1

Conditions treated

General Infections · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official44 products · Rs 3.88 – Rs 7,781.51
DVAGO1 products · Rs 826.79 – Rs 826.79
Servaid1 products · Rs 814.53 – Rs 814.53
Median across source: Rs 814.53

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 132 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxycillinAmoxycillin Base
Genix Pharma Private Limited holds 156 molecules not in this portfolio
000 I.UAceclofenacAcyclovirAlbendazoleAlfacalcidolAmikacin
MEDISURE LABORATORIES PAKISTAN (PVT.) LTD. holds 74 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAmlodipineArtemetherAscorbic AcidAtorvastatin

Get the full profile for Lucky

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.